NovoCure

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. 

CEO
Asaf Danziger
CEOAsaf Danziger
Employees
1,167
Employees1,167
Headquarters
St. Helier, Jersey
HeadquartersSt. Helier, Jersey
Founded
2000
Founded2000
Employees
1,167
Employees1,167

NVCR Key Statistics

Market cap
8.80B
Market cap8.80B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
448.85K
Average volume448.85K
High today
High today
Low today
Low today
Open price
$77.31
Open price$77.31
Volume
0.00
Volume0.00
52 Week high
$94.00
52 Week high$94.00
52 Week low
$56.39
52 Week low$56.39

NVCR News

Benzinga 3d
NovoCure shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight. - NovoCure - Benzinga

Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use t...

NovoCure shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight. - NovoCure - Benzinga

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
14.3%
Sell
28.6%

NVCR Earnings

-$0.26
-$0.17
-$0.07
$0.02
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.